Reaction

Leukoerythroblastosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 100 reports · 4 co-occurring drugs

As of the last recalculation, Leukoerythroblastosis appears in 100 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is IFOSFAMIDE (PRR 273.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ifosfamide22273.0273.2
Fludarabine Phosphate22149.0149.1
Vincristine Sulfate17145.3145.4
Romiplostim7104.0104.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.